Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

SHE:300534 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	843.87	886.96	1,043	1,080	799.68	287.81
Revenue Growth	-20.56%	-14.92%	-3.48%	35.06%	177.85%	12.91%
Gross Profit Gross Profit Growth	563.23	603.55	751.13	693.26	458.06	92.33
Operating Income Operating Income Growth	78.73	87.47	96.02	81.82	56.31	-9.31
Net Income Net Income Growth	49.37	43.95	24.48	61.65	38.79	-9.11
Earnings Per Share EPS Growth	0.16	0.14	0.08	0.20	0.13	-0.03
EPS Growth	129.14%	79.55%	-60.28%	58.87%	-	-

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
China China Growth	874.83	1,034	1,071	789.4	275.55
Foreign Foreign Growth	12.13	8.4	8.63	10.28	12.26
Total Total Growth	886.96	1,043	1,080	799.68	287.81

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	234.61	241.33	310.02	288.95	369.24	99.12
Total Debt Total Debt Growth	105.52	132.51	114.68	144.54	-	-
Net Cash (Debt) Net Cash Growth	129.09	108.82	195.34	144.4	369.24	99.12
Net Cash Growth	-25.80%	-44.29%	35.27%	-60.89%	272.52%	105.97%
Net Cash Per Share Net Cash Per Share Growth	0.43	0.36	0.64	0.48	1.22	0.33

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	29.85	-6.54	214.92	96.53	267.44	51.13
Capital Expenditures CapEx Growth	-44.61	-43.36	-77.69	-126.36	-25.41	-0.41
Free Cash Flow Free Cash Flow Growth	-14.76	-49.9	137.23	-29.83	242.03	50.72
Free Cash Flow Growth	-	-	-	-	377.18%	103.30%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	66.74%	68.05%	72.05%	64.19%	57.28%	32.08%
Operating Margin	9.33%	9.86%	9.21%	7.58%	7.04%	-3.24%
Pretax Margin	10.61%	9.15%	9.76%	8.98%	8.27%	-1.65%
Profit Margin	5.85%	4.96%	2.35%	5.71%	4.85%	-3.16%
FCF Margin	-1.75%	-5.63%	13.16%	-2.76%	30.27%	17.62%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Dividend Per Share Dividend Per Share Growth	0.040	0.040	0.040	0.020
Dividend Per Share Growth	0%	0%	100.00%	-
Dividend Yield	0.28%	0.42%	0.46%	0.21%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	81.15	65.43	107.82	48.57	69.37	-
P/FCF Ratio	-	-	19.23	-	11.12	88.04
PS Ratio	4.75	3.24	2.53	2.77	3.37	15.51

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error